The Technical Analyst

Johnson & Johnson [JNJ]

Exchange: NYSE Sector: Healthcare Industry: Drug Manufacturers—General

Johnson & Johnson Price, Forecast, Insider, Ratings, Fundamentals & Signals

0.44% $149.60

America/New_York / 9 mai 2024 @ 12:59

FIND ALL MARKETS FIND ALL STOCKS LISTED @ NYSE Live Signal Oslo Live Signal Nasdaq Live Signal Crypto

Johnson & Johnson: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap:	360 039 mill
EPS:	6.74
P/E:	22.20
Earnings Date:	Jul 17, 2024
SharesOutstanding:	2 406.68 mill
Avg Daily Volume:	7.61 mill

RATING 2024-05-09
S-
Strong Buy

RATINGS
Rating CashFlow:	Buy
Return On Equity:	Strong Buy
Return On Asset:	Buy
DE:	Buy
P/E:	Buy
Price To Book:	Strong Buy

QUARTER GROWTHS
	1/23	2/23	3/23	4/23	4/23	1/24
Revenue
Gr.Profit
Ebit
Asset
Debt

PE RATIO: COMPANY / SECTOR
1.44x
Company: PE 22.20 \| sector: PE 15.43

PE RATIO: COMPANY / INDUSTRY
0.92x
Company: PE 22.20 \| industry: PE 24.13

DISCOUNTED CASH FLOW VALUE
$147.03 (-1.72%) $-2.57
Date: 2024-05-09

Expected Trading Range (DAY)
$ 147.23 - 151.83 ( +/- 1.54%)
ATR Model: 14 days

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Reed John C	Sell	22 255	Restricted Share Units
2024-05-01	Reed John C	Buy	22 255	Common Stock
2024-05-01	Reed John C	Sell	10 984	Common Stock
2024-04-25	Beckerle Mary C	Buy	1 386	Deferred Share Units
2024-04-25	Hewson Marillyn A	Buy	1 386	Deferred Share Units

INSIDER POWER
66.28
Last 100 transactions
Buy: 848 454 \| Sell: 169 206

Forecast: 14:38 - $149.55

Live Trading Signals (every 1 min)

Forecast 1: 13:08 - $149.63

Forecast 2: 13:58 - $149.58

Forecast 3: 14:38 - $149.55

SCORE
10.00
Buy

Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022

Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD

Volume Signals
Price	$149.60 (0.44% )
Volume	2.24 mill
Avg. Vol.	7.61 mill
% of Avg. Vol	29.40 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Johnson & Johnson

Last 12 Months

RSI

Intraday RSI14 chart for Johnson & Johnson

Last 10 Buy & Sell Signals For JNJ

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date	Signal	@	Closed	%

JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Last 10 Buy Signals

Date	Signal	@
SUIUSD	May 9 - 12:56	0.997
OGUSD	May 9 - 12:57	4.36
FUTU	May 9 - 12:57	HKD70.00
JUVUSD	May 9 - 12:57	2.41
LMWRUSD	May 9 - 12:57	0.926
LAZIOUSD	May 9 - 12:57	2.68
DEGOUSD	May 9 - 12:57	2.19
DAOUSD	May 9 - 12:56	$0.870
WFTMUSD	May 9 - 12:57	0.681
EOSUSD	May 9 - 12:56	$0.802

Latest Press Releases

2024-05-01 08:26:00 - Press Release

Beasley Allen Law Firm: Attorneys For Women Harmed By Johnson & Johnson's Talcum Powder Resist Company's Attempt To Stuff Ballot Box In Unprecedented Third Attempted Bankruptcy

Montgomery, ala.--(business wire)--a coalition of attorneys representing tens of thousands of women harmed by johnson & johnson's talc-based powder products is challenging j&j's attempt to weaponize unrelated claims in exchange for votes on a payment plan that would cheat victims legitimately harmed by talc. it's a shocking new legal strategy that could strip consumers of their constitutional rights and allow major corporations to evade responsibility for the harm caused by defective pr.

2024-05-01 06:30:00 - Press Release

Johnson & Johnson Announces Plan By Its Subsidiary, Llt Management Llc, To Resolve All Current And Future Ovarian Cancer Talc Claims Through A Consensual “prepackaged” Reorganization

New brunswick, n.j.--(business wire)--johnson & johnson (nyse: jnj) (the “company”) today announced a proposed plan of reorganization (the “plan”) by its subsidiary, llt management llc ("llt"), for the comprehensive and final resolution of all current and future claims related to ovarian cancer arising from cosmetic talc litigation against it and its affiliates in the united states. “the plan is the culmination of our consensual resolution strategy that we announced last october,” said erik.

2024-04-24 14:35:00 - Press Release

Pbirx Growth Fueled By Johnson & Johnson Erisa Lawsuit

Milford, conn.--(business wire)-- #soc2--pbirx, a pharmacy benefits consulting and auditing firm, sees growth from concerns over alleged fiduciary breach lawsuit against johnson & johnson.

2024-04-22 16:30:00 - Press Release

Johnson & Johnson To Participate In The Bernstein's 40th Annual Strategic Decisions Conference (sdc)

New brunswick, n.j.--(business wire)--johnson & johnson (nyse: jnj) will participate in the bernstein's 40th annual strategic decisions conference (sdc) on wednesday, may 29th, at the new york hilton midtown, new york, ny. joaquin duato, chairman and chief executive officer will represent the company in a session scheduled at 1:30 pm (eastern time). this live audio webcast will be available to investors and other interested parties by accessing the johnson & johnson website at www.inves.

2024-04-19 20:50:00 - Press Release

Illinois Jury Awards $45 Million In Mesothelioma Case Against Johnson & Johnson, Kenvue, Inc.

Chicago--(business wire)--a jury in the circuit court of cook county in chicago found johnson & johnson (nyse:jnj) and two subsidiaries liable in the asbestos-related death of a mother and grandmother, and awarded her family $45 million in damages. the jury concluded that theresa garcia's lifelong use of talc-based johnson's baby powder and other products was the cause of her mesothelioma, an always-fatal cancer of the lining of the lungs caused by exposure to asbestos. laboratory testing h.

Latest News

2024-05-09 05:07:00 - The Motley Fool

What Is the Dividend Payout for Johnson & Johnson Stock?

Johnson & Johnson increased its dividend payout earlier this year. The healthcare company has a stellar record of paying dividends.

Full Story

2024-05-08 16:39:38 - InvestorPlace

The 3 Most Undervalued S&P 500 Stocks to Buy in May 2024

Most investors are well aware that the S&P 500 was down 1.6% at the end of April. However, the ongoing earnings season and the promise of at least one rate cut later in the year have helped stocks keep momentum.

Full Story

2024-05-08 13:55:30 - InvestorPlace

Steady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024

The stock market has performed well so far this year, with benchmark indices rising over 9%. After recovering from a dip in April, indices are nearing record highs set in March and could soon score new records.

Full Story

2024-05-08 12:04:44 - Seeking Alpha

4 Dividend Aristocrats To Buy In May Plus 4 To Watch

Full Story

2024-05-08 09:38:22 - Finbold

Here's why you should buy these 3 stocks and hold them forever

Often overlooked, especially in times of AI revolution, the healthcare market is always a safe bet for investors, as it is a multiple trillion, highly innovative industry with no drawbacks like lack of demand per se.

Full Story

2024-05-06 13:37:50 - InvestorPlace

Steady Dividend Plays: 3 Aristocrat Stocks to Own Now

On Wall Street, many income-focused investors prioritize long-term stability and reliability over short-term volatility. Enter the Dividend Aristocrat stocks.

Full Story

2024-05-06 04:59:33 - Finbold

ChatGPT picks 3 stocks to buy and hold forever

It is often said that trying to beat the stock market by perfecting the timing of each trade is far more trouble than it is worth and could lead to far worse results than making strong picks and just sticking with the shares, no matter the current and temporary trials and tribulations.

Full Story

2024-05-05 08:56:12 - Seeking Alpha

Buy 1 Dog Of The Dow In May; See 4 More Play

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation.is also a consideration.”–DowJones&Co. The highest-yield 10 stocks are May's Dogs of the Dow: HD, KO, AMGN, JNJ, CSCO, IBM, CVX, DOW, MMM, and VZ. They now average a 4.17% annual yield, as prices. Thirty Dow stocks represent nine of eleven sectors. DowJones tracks utilities as a separate index and omits real estate. Broker top-ten target-estimated May net-gains ranged 17.6%-38%, topped by INTC 5/1/24.

Full Story

2024-05-04 09:00:00 - Seeking Alpha

5 Relatively Secure And Cheap Dividend Stocks To Invest In - May 2024

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields about 3.7%, we present two other groups of five DGI stocks each, with the goal of moderate to high yields.

Full Story

2024-05-03 10:01:24 - Zacks Investment Research

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Full Story

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.